Sec Form 13D Filing - Petrus Advisers Ltd. filing for Criteo S.A. (CRTO) - 2024-02-27

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 13D

 

Under the Securities Exchange Act of 1934
(Amendment No. )*

 

  Criteo S.A.  
  (Name of Issuer)  
     
  American Depositary Shares, each representing one Ordinary Share, nominal value €0.025 per share  
  (Title of Class of Securities)  
     
  226718104  
  (CUSIP Number)  
     
 

Connie Neumann

Office and compliance manager

Petrus Advisers Ltd

Eighth Floor, 6 New Street Square, New Fetter Lane

London EC4A 3AQ, United Kingdom

+44 20 7933 8831

 
  (Name, Address and Telephone Number of Person Authorized to  
  Receive Notices and Communications)  
     
  February 22, 2024  
  (Date of Event which Requires Filing of this Statement)  

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☒

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Section 240.13d-7 for other parties to whom copies are to be sent.

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

CUSIP No. 226718104 13D Page 2 of 11 pages

 

1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
  Petrus Advisers Ltd.
   
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*    
  (see instructions) (a)
    (b)
3 SEC USE ONLY    
       
       
4 SOURCE OF FUNDS* (see instructions)    
  OO    
       
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED    
  PURSUANT TO ITEMS 2(d) OR 2(e)  
       
       
6 CITIZENSHIP OR PLACE OF ORGANIZATION    
  United Kingdom    
       
  7 SOLE VOTING POWER

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH:

  0
   
8 SHARED VOTING POWER
  2,446,674
   
9 SOLE DISPOSITIVE POWER
  0
   
10 SHARED DISPOSITIVE POWER
  2,922,248
   

11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
  2,922,248  
       
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
  (see instructions)  
       
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)    
  5.29%1    
       
14 TYPE OF REPORTING PERSON* (see instructions)    
  FI    
       

 

 

1Based on 55,227,016 Shares (as defined herein) outstanding as of February 16, 2024, as disclosed in the Issuer’s Annual Report on Form 10-K filed on February 23, 2024.

 

 

 

 

CUSIP No. 226718104 13D Page 3 of 11 pages

 

1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
  Klaus Umek
   
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*    
  (see instructions) (a)
    (b)
3 SEC USE ONLY    
       
       
4 SOURCE OF FUNDS* (see instructions)    
  OO, PF    
       
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED    
  PURSUANT TO ITEMS 2(d) OR 2(e)  
       
       
6 CITIZENSHIP OR PLACE OF ORGANIZATION    
  Austrian    
       
  7 SOLE VOTING POWER

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH:

  39,649
   
8 SHARED VOTING POWER
  2,446,674
   
9 SOLE DISPOSITIVE POWER
  39,649
   
10 SHARED DISPOSITIVE POWER
  2,922,248
   
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
  2,961,897  
       
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
  (see instructions)  
       
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)    
  5.36%2    
       
14 TYPE OF REPORTING PERSON* (see instructions)    
  IN, HC    
       

 

 

2Based on 55,227,016 Shares outstanding as of February 16, 2024, as disclosed in the Issuer’s Annual Report on Form 10-K filed on February 23, 2024.

 

 

 

 

CUSIP No. 226718104 13D Page 4 of 11 pages

 

1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
  Till Hufnagel
   
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*    
  (see instructions) (a)
    (b)
3 SEC USE ONLY    
       
       
4 SOURCE OF FUNDS* (see instructions)    
  OO, PF    
       
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED    
  PURSUANT TO ITEMS 2(d) OR 2(e)  
       
       
6 CITIZENSHIP OR PLACE OF ORGANIZATION    
  German    
       
  7 SOLE VOTING POWER

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH:

  168,061
   
8 SHARED VOTING POWER
  2,446,674
   
9 SOLE DISPOSITIVE POWER
  168,061
   
10 SHARED DISPOSITIVE POWER
  2,922,248
   
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
  3,090,309  
       
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
  (see instructions)  
       
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)    
  5.60%3    
       
14 TYPE OF REPORTING PERSON* (see instructions)    
  IN, HC    
       

 

 

3Based on 55,227,016 Shares outstanding as of February 16, 2024, as disclosed in the Issuer’s Annual Report on Form 10-K filed on February 23, 2024.

 

 

 

 

CUSIP No. 226718104 13D Page 5 of 11 pages

 

Item 1. Security and Issuer.

 

This statement on Schedule 13D relates to the American Depositary Shares issued within the framework of the Amended and Restated Deposit Agreement dated December 28, 2021 between Criteo S.A., the Bank of New York Mellon and owners and holders of American Depositary Shares (the “ADS”), each representing one ordinary share, nominal value €0.025 per share, (the “Shares”) of Criteo S.A., a French société anonyme whose headquarters are located 32 rue Blanche, 75009 Paris, France (the “Issuer”).

 

       
Item 2. Identity and Background.    
       
(a-c)  This statement is being filed by the following persons (hereafter referred to as a “Reporting Person” individually and “Reporting Persons” collectively):

 

NAME  ADDRESS  OCCUPATION
Petrus Advisers Ltd. (“Petrus”)  Eighth Floor, 6 New Street Square, New Fetter Lane
London EC4A 3AQ, United Kingdom
  The principal business of Petrus Advisers Ltd. is to hold securities for investment purposes and to act as an investment manager or portfolio adviser for certain investment vehicles and certain managed accounts.
       
Till Hufnagel  100 Pall Mall,
London SW1Y 5NQ, United Kingdom
  Hufnagel’s principal business is to serve as partner of Petrus Advisers Ltd.
       
Klaus Umek  100 Pall Mall,
London SW1Y 5NQ, United Kingdom
  Umek’s principal business is to serve as the managing partner of Petrus Advisers Ltd.

 

(d-e)  During the last five years, none of the persons or entities listed above has been (i) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors); or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
       
(f)  Petrus is a private limited company organized under the laws of the United Kingdom. Klaus Umek is a citizen of Austria and Till Hufnagel is a citizen of Germany.
       
Item 3. Source and Amount of Funds or Other Consideration.  

 

A total of approximately €3.3 million, excluding commissions, was paid to acquire the ADS, including options to acquire ADS, purchased since the filing of the Reporting Persons’ Schedule 13G, filed with the Securities and Exchange Commission on December 1, 2023. The ADS reported herein were purchased using the working capital of the investment vehicles and managed accounts that own the ADS directly, for which Petrus serves as investment manager or portfolio adviser, as well as the personal funds of the private individuals who have signed powers of attorney in favor of Petrus, Mr. Hufnagel and Mr. Umek.

 

The Reporting Persons may effect purchases of ADS through margin accounts maintained with prime brokers, which extend margin credit as and when required to open or carry positions in their margin accounts, subject to applicable margin regulations, stock exchange rules and such firms’ credit policies. Positions in the ADS may be held in margin accounts and may be pledged as collateral security for the repayment of debit balances in such accounts. Since other securities may be held in such margin accounts, it may not be possible to determine the amounts, if any, of margin used to purchase the ADS.

       
Item 4. Purpose of Transaction.    
     
The Reporting Persons believe that the ADS represent an attractive investment opportunity as the Issuer’s value could substantially increase subject to revising its strategy, and possibly by being the target of a tender offer. On February 22, 2024, the Reporting Persons sent a public letter (the “Letter”) asking the Issuer to (i) prepare an investor day as soon as possible to explain its Retail Media strategy and a new mid-term plan, (ii) accelerate the existing share buyback by means of a substantial self-tender of up to $150 million, (iii) no later than Q4 2024, initiate a comprehensive strategic review, including to evaluate all ownership options, and (iv) refresh the board of directors of the Issuer (the “Board”) by adding independent candidates whom the Reporting Persons will propose, with the aim of strengthening capital markets acumen and industry experience. The Reporting Persons further seek to engage in a dialogue with the Issuer’s managers and Board members to maximize ADS and shareholder value. The Reporting Persons may also seek to communicate with shareholders and other third parties about such discussions and strategy.

 

 

 

 

CUSIP No. 226718104 13D Page 6 of 11 pages

 

Depending on the evolution of the market for the ADS, as well as the outcome of (i) the Reporting Persons’ discussions with the Issuer’s managers and Board members (regarding in particular the Reporting Persons’ proposal to submit the candidacy of independent Board members to the next general meeting), (ii) the publication of the Letter, and (iii) the change, if any, in the Issuer’s strategy, the Reporting Persons may seek to obtain the appointment of new Board members, or the dismissal of existing Board members, at the Issuer’s next general meeting.

 

A copy of the Letter is filed as an exhibit to this statement on Schedule 13D and is incorporated herein by reference.

 

The Reporting Persons intend to review their investment in the Issuer on a continuing basis and depending upon various factors, including without limitation, the Issuer’s financial position and strategic direction, the outcome of any discussions referenced above, overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of securities of the Issuer at prices that would make the purchase or sale of such securities desirable, may endeavor (i) to increase or decrease their position in the Issuer through, among other things, the purchase or sale of securities of the Issuer, including through transactions involving the ADS, the Shares and/or other equity, debt, notes, other securities, or derivative or other instruments that are based upon or relate to the value of securities of the Issuer in the open market or in private transactions, including through a trading plan created under Rule 10b5-1(c) or otherwise, on such terms and at such times as the Reporting Persons may deem advisable and/or (ii) to enter into transactions that increase or hedge their economic exposure to the ADS and the Shares without affecting their beneficial ownership of the ADS and the Shares. In addition, the Reporting Persons may, at any time and from time to time, (i) review or reconsider their position and/or change their purpose and/or formulate plans or proposals with respect thereto and (ii) consider or propose one or more of the actions described in subparagraphs (a) - (j) of Item 4 of Schedule 13D.

 

Item 5. Interest in Securities of the Issuer.    
       
(a) See rows (11) and (13) of pages 2, 3 and 4 of this Schedule 13D for the aggregate number of ADS and percentage of ADS beneficially owned by the Reporting Persons. These amounts include an aggregate 1,550,000 ADS that the Reporting Persons have the right to acquire within 60 days upon exercise of long standardized call options. The aggregate percentage of ADS reported beneficially owned by the Reporting Persons is based upon 55,227,016 Shares outstanding as of February 16, 2024, as disclosed in the Issuer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed by the Issuer with the Securities and Exchange Commission on February 23, 2024.
       
(b) See rows (7) through (10) of pages 2, 3 and 4 of this Schedule 13D for the ADS as to which the Reporting Persons have the sole or shared power to vote or direct the vote and sole or shared power to dispose or direct the disposition. Each of Petrus, Mr. Hufnagel and Mr. Umek may be deemed to share voting power and share dispositive power over the ADS and options to acquire ADS held directly by the investment vehicles and managed accounts for which Petrus serves as investment manager or portfolio adviser and the private individuals who have signed powers of attorney in favor of Petrus.
       
(c) The transactions in the ADS effected by the Reporting Persons during the past sixty (60) days, which were all in the open market, are set forth on Schedule 1 attached hereto.
       
(d) The ADS reported on this statement on Schedule 13D as being beneficially owned by the Reporting Persons include ADS and options to acquire ADS owned directly by certain investment vehicles and managed accounts for which Petrus serves as investment manager or portfolio adviser, private individuals who have signed powers of attorney in favor of Petrus, and Mr. Hufnagel and Mr. Umek, each of which is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the ADS and options to acquire ADS held directly by them.
       
(e) Not applicable.    

 

 

Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

 

The information set forth in each of Item 3 and Item 5 of this Schedule 13D is incorporated herein by reference.

 

In connection with filing this Schedule 13D jointly, pursuant to Rule 13d-1(k)(1) under the Act, the Reporting Persons entered into a Joint Filing Agreement, a copy of which is filed as an exhibit to this statement on Schedule 13D and is incorporated herein by reference.

 

Except as otherwise set forth in this Schedule 13D, there are no contracts, arrangements, understandings or relationships between the Reporting Persons named in Item 2 and any other person with respect to any securities of the Issuer.

 

 

 

 

CUSIP No. 226718104 13D Page 7 of 11 pages

 

Item 7. Material to be Filed as Exhibits.    
     
Exhibit 1 – Joint Filing Agreement, dated February 27, 2024.
 
Exhibit 2 – Letter to the Issuer, dated February 22, 2024.
       

 

 

 

 

CUSIP No. 226718104 13D Page 8 of 11 pages

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

    Petrus Advisers Ltd.
     
  By: /s/ Suraj Shah
    Suraj Shah
    (Name)
     
    Director
    (Title)
     
    February 27, 2024
    (Date)

 

  By: /s/ Klaus Umek
    Klaus Umek
     
    February 27, 2024
    (Date)

 

  By: /s/ Till Hufnagel
    Till Hufnagel
     
    February 27, 2024
    (Date)

 

 

 

 

CUSIP No. 226718104 13D Page 9 of 11 pages

 

SCHEDULE 1

 

Transactions in the ADS of the Issuer by the Reporting Persons During the Past Sixty (60) Days

 

The following table sets forth all transactions in the ADS effected during the past sixty (60) days by the Reporting Persons. Except as noted below, all such transactions were effected in the open market through brokers and the price per share excludes commissions.

 

Reporting Person  Type  Quantity4  Name of Security  Price5  Trade Date6
Petrus Advisers LTD  Sell  -1,518  CRTO US Equity  25.20593  20231227

Klaus Umek

 

Sell

 

-600

 

CRTO US Equity

 

25.0071

 

20231227

Petrus Advisers LTD  Sell  -2,889  CRTO US Equity  25.10727  20231228
Petrus Advisers LTD  Sell  -1,712  CRTO US Equity  25.12770  20231228
Petrus Advisers LTD  Sell  -50,000  CRTO US Equity  25.19000  20231229
Petrus Advisers LTD  Buy  1,000  CRTO US Equity  25.09900  20231229
Petrus Advisers LTD  Buy  25,000  CRTO US Equity  25.29758  20231229
Petrus Advisers LTD  Buy  30,000  CRTO US Equity  25.28340  20231229
Petrus Advisers LTD  Buy  34,000  CRTO US Equity  25.28418  20231229
Klaus Umek 

Sell

 

-4,832

 

CRTO US Equity

 

25.0257

 

20231229

Petrus Advisers LTD  Buy  45,000  CRTO US Equity  24.99485  20240102
Petrus Advisers LTD  Buy  50,000  CRTO US Equity  24.84981  20240102
Petrus Advisers LTD  Sell  -5,000  CRTO US Equity  24.74000  20240104
Petrus Advisers LTD  Buy  250  CRTO US Equity  24.50980  20240104
Petrus Advisers LTD  Buy  10,380  CRTO US Equity  24.45797  20240104
Petrus Advisers LTD  Sell  -22,300  CRTO US Equity  24.57729  20240105
Petrus Advisers LTD  Buy  11,269  CRTO US Equity  24.26476  20240105
Petrus Advisers LTD  Buy  3,244  CRTO US Equity  24.23029  20240109
Petrus Advisers LTD  Sell  -37,719  CRTO US Equity  24.81149  20240111
Petrus Advisers LTD  Buy  1,500  CRTO US Equity  24.42397  20240111
Petrus Advisers LTD  Sell  -15,721  CRTO US Equity  25.00029  20240112
Petrus Advisers LTD  Buy  15,000  CRTO US Equity  24.86574  20240112
Petrus Advisers LTD  Buy  2,500  CRTO US Equity  24.46904  20240116
Petrus Advisers LTD  Buy  2,500  CRTO US Equity  24.49454  20240116
Petrus Advisers LTD  Sell  -100  CRTO US Equity  24.30000  20240117
Klaus Umek 

Sell

 

-55,560

 

CRTO US Equity

 

24.4358

 

20240117

Petrus Advisers LTD  Sell  -4,168  CRTO US Equity  24.43117  20240118
Petrus Advisers LTD  Sell  -10,077  CRTO US Equity  24.62221  20240119
Petrus Advisers LTD  Assignment 

5,000

500,000

 

CRTO US 01/19/24 P25 Equity

CRTO US Equity

 

0.00000

25.00000

  20240119
Petrus Advisers LTD  Sell  -2,392  CRTO US Equity  24.88343  20240122
Petrus Advisers LTD  Sell  -9,100  CRTO US Equity  25.16000  20240123
Petrus Advisers LTD  Sell  -1,547  CRTO US Equity  25.21319  20240123
Petrus Advisers LTD  Sell  -10,000  CRTO US Equity  25.39511  20240124
Petrus Advisers LTD  Sell  -9,735  CRTO US Equity  25.45067  20240124
Petrus Advisers LTD  Buy  2,000  CRTO US 02/16/24 C30 Equity  0.25000  20240124

 

 

4Quantity of options reflects number of contracts, with each contract representing 100 ADS.
5Price per share in US dollars.
6Trade dates are following the format YYYYMMDD.

 

 

 

 

CUSIP No. 226718104 13D Page 10 of 11 pages

 

Petrus Advisers LTD  Buy  1,000  CRTO US Equity  25.5640  20240125
Petrus Advisers LTD  Sell  -13,757  CRTO US Equity  25.73459  20240126
Petrus Advisers LTD  Sell  -10,061  CRTO US Equity  25.70472  20240126

Klaus Umek

  Buy 

13,730

 

CRTO US Equity

 

25.85765

 

20240126

Petrus Advisers LTD  Sell  -10,996  CRTO US Equity  25.91127  20240129
Petrus Advisers LTD  Sell  -2,946  CRTO US Equity  26.01494  20240129
Petrus Advisers LTD  Sell  -3,692  CRTO US Equity  26.13014  20240130
Petrus Advisers LTD  Sell  -2,128  CRTO US Equity  26.13919  20240130
Klaus Umek  Buy  3,500  CRTO US Equity  26.024  20240130
Till Hufnagel  Buy  10,000  CRTO US Equity  26.1247  20240130
Petrus Advisers LTD  Buy  2,000  CRTO US Equity  26.04555  20240131
Petrus Advisers LTD  Buy  20,000  CRTO US Equity  26.14175  20240131
Petrus Advisers LTD  Buy  20,000  CRTO US Equity  26.14425  20240131
Petrus Advisers LTD  Sell  -240,856  CRTO US Equity  24.72210  20240201
Petrus Advisers LTD  Sell  -94,144  CRTO US Equity  24.72210  20240201
Petrus Advisers LTD  Buy  250  CRTO US Equity  26.25800  20240201
Petrus Advisers LTD  Buy  5,000  CRTO US 07/19/24 C25 Equity  3.00000  20240201
Petrus Advisers LTD  Sell  -6,400  CRTO US Equity  26.38500  20240202
Petrus Advisers LTD  Sell  -100  CRTO US Equity  26.40000  20240202
Petrus Advisers LTD  Buy  25,000  CRTO US Equity  26.04621  20240205
Petrus Advisers LTD  Sell  -4,830  CRTO US Equity  26.20041  20240206
Petrus Advisers LTD  Sell  -1,094  CRTO US Equity  26.20411  20240206
Petrus Advisers LTD  Sell  -50,000  CRTO US Equity  30.77579  20240207
Petrus Advisers LTD  Sell  -25,000  CRTO US Equity  30.65444  20240207
Petrus Advisers LTD  Sell  -25,000  CRTO US Equity  30.78328  20240207
Petrus Advisers LTD  Sell  -25,000  CRTO US Equity  30.85994  20240207
Petrus Advisers LTD  Sell  -25,000  CRTO US Equity  30.70018  20240207
Petrus Advisers LTD  Sell  -16,450  CRTO US Equity  30.77751  20240207
Petrus Advisers LTD  Sell  -15,200  CRTO US Equity  30.93281  20240207
Petrus Advisers LTD  Sell  -15,000  CRTO US Equity  30.91514  20240207
Petrus Advisers LTD  Sell  -15,000  CRTO US Equity  30.82196  20240207
Petrus Advisers LTD  Sell  -8,550  CRTO US Equity  30.68247  20240207
Petrus Advisers LTD  Sell  -1,100  CRTO US Equity  30.9100  20240207
Petrus Advisers LTD  Sell  -600  CRTO US Equity  31.00333  20240207
Petrus Advisers LTD  Buy  5,000  CRTO US Equity  31.51830  20240207

Klaus Umek

 

Sell

 

-23,790

 

CRTO US Equity

 

30.41270

 

20240207

Petrus Advisers LTD  Sell  -28,094  CRTO US Equity  32.02819  20240208
Petrus Advisers LTD  Sell  -25,000  CRTO US Equity  31.64675  20240208
Petrus Advisers LTD  Sell  -25,000  CRTO US Equity  31.78200  20240208
Petrus Advisers LTD  Sell  -25,000  CRTO US Equity  32.00063  20240208
Petrus Advisers LTD  Sell  -25,000  CRTO US Equity  32.02503  20240208
Petrus Advisers LTD  Sell  -25,000  CRTO US Equity  32.17000  20240208
Petrus Advisers LTD  Sell  -20,000  CRTO US Equity  31.50428  20240208
Petrus Advisers LTD  Sell  -1,906  CRTO US Equity  31.92099  20240208
Petrus Advisers LTD  Sell  -500  CRTO US Equity  32.30200  20240208
Petrus Advisers LTD  Buy  10,905  CRTO US Equity  26.175  20240208
Petrus Advisers LTD  Buy  14,000  CRTO US Equity  26.175  20240208

 

 

 

 

CUSIP No. 226718104 13D Page 11 of 11 pages

 

Petrus Advisers LTD   Buy   24,185   CRTO US Equity   26.175   20240208
Petrus Advisers LTD   Sell   -32,500   CRTO US Equity   31.90000   20240209
Petrus Advisers LTD   Sell   -2,500   CRTO US 07/19/24 C35 Equity   2.10000   20240209
Petrus Advisers LTD   Buy   2,500   CRTO US 07/19/24 C32.5 Equity   3.17000   20240209
Petrus Advisers LTD   Sell   -10,200   CRTO US Equity   32.29186   20240212
Petrus Advisers LTD   Sell   -4,052   CRTO US Equity   32.21594   20240212
Petrus Advisers LTD   Buy   6,500   CRTO US Equity   32.17424   20240212
Petrus Advisers LTD   Sell   -6,750   CRTO US Equity   32.01   20240213
Petrus Advisers LTD   Buy   2,500   CRTO US Equity   31.97153   20240213
Klaus Umek   Buy   6,750   CRTO US Equity   32.01   20240213
Petrus Advisers LTD   Exercise  

-2,000

200,000

 

CRTO US 02/16/24 C30 Equity

CRTO US Equity

 

0.00000

30.00000

  20240216
Petrus Advisers LTD   Sell   -63,000   CRTO US Equity   31.00000   20240221
Petrus Advisers LTD   Sell   -3,000   CRTO US 10/18/24 C35 Equity   2.55000   20240221
Petrus Advisers LTD   Buy   1,681   CRTO US Equity   31.28570   20240221
Petrus Advisers LTD   Buy   2,403   CRTO US Equity   31.28570   20240221
Petrus Advisers LTD   Buy   2,621   CRTO US Equity   31.76980   20240221
Petrus Advisers LTD   Buy   2,974   CRTO US Equity   31.28570   20240221
Petrus Advisers LTD   Buy   3,000   CRTO US 10/18/24 C30 Equity   4.90000   20240221
Petrus Advisers LTD   Buy   4,901   CRTO US Equity   31.76980   20240221
Petrus Advisers LTD   Buy   6,018   CRTO US Equity   31.76980   20240221